J. Mark Farrant

2.5k total citations · 1 hit paper
18 papers, 1.7k citations indexed

About

J. Mark Farrant is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Genetics. According to data from OpenAlex, J. Mark Farrant has authored 18 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Surgery, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Genetics. Recurrent topics in J. Mark Farrant's work include Liver Diseases and Immunity (6 papers), Esophageal and GI Pathology (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). J. Mark Farrant is often cited by papers focused on Liver Diseases and Immunity (6 papers), Esophageal and GI Pathology (4 papers) and Gallbladder and Bile Duct Disorders (4 papers). J. Mark Farrant collaborates with scholars based in United Kingdom, United States and Taiwan. J. Mark Farrant's co-authors include Simon Travis, Christopher J. Ricketts, D P Jewell, M G W Kettlewell, Daniel J. Nolan, Roger Williams, David Westaby, Karen M. Hayllar, John Karani and Bernard Portmann and has published in prestigious journals such as The Lancet, Gastroenterology and PLoS ONE.

In The Last Decade

J. Mark Farrant

18 papers receiving 1.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Predicting outcome in severe ulcerative colitis.

1996 539 citations Simon Travis, J. Mark Farrant et al. Gut profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J. Mark Farrant United Kingdom	13	839	816	753	554	400	18	1.7k
Hans Verbaan Sweden	19	400 0.5×	1.6k 1.9×	905 1.2×	1.0k 1.9×	46 0.1×	44	2.0k
Sergio Peralta Italy	21	350 0.4×	474 0.6×	285 0.4×	322 0.6×	136 0.3×	49	1.6k
C. Penna France	19	727 0.9×	342 0.4×	408 0.5×	200 0.4×	438 1.1×	52	1.6k
Judith Collins United States	9	354 0.4×	1.0k 1.3×	1.3k 1.7×	89 0.2×	112 0.3×	18	1.7k
Montserrat Andreu Spain	19	427 0.5×	523 0.6×	549 0.7×	67 0.1×	207 0.5×	45	1.3k
G. D’Haens Netherlands	12	380 0.5×	851 1.0×	985 1.3×	75 0.1×	75 0.2×	37	1.2k
L. H. Weiland United States	21	744 0.9×	424 0.5×	207 0.3×	147 0.3×	419 1.0×	45	1.8k
Makoto Ohbu Japan	18	420 0.5×	374 0.5×	141 0.2×	319 0.6×	146 0.4×	60	1.1k
Gianfranco Lauletta Italy	23	382 0.5×	657 0.8×	96 0.1×	1.2k 2.2×	255 0.6×	57	1.9k
P. Pescatore Luxembourg	14	487 0.6×	585 0.7×	762 1.0×	33 0.1×	212 0.5×	33	1.3k

Countries citing papers authored by J. Mark Farrant

Since Specialization

Citations

This map shows the geographic impact of J. Mark Farrant's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Mark Farrant with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Mark Farrant more than expected).

Fields of papers citing papers by J. Mark Farrant

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Mark Farrant. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Mark Farrant. The network helps show where J. Mark Farrant may publish in the future.

Co-authorship network of co-authors of J. Mark Farrant

This figure shows the co-authorship network connecting the top 25 collaborators of J. Mark Farrant. A scholar is included among the top collaborators of J. Mark Farrant based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Mark Farrant. J. Mark Farrant is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Burke, Zoë D., Yu Chen, Weiyuan Yu, et al.. (2016). Hnf4α is a key gene that can generate columnar metaplasia in oesophageal epithelium. Differentiation. 93. 39–49. 21 indexed citations

Sinha, Amitasha, et al.. (2013). PTU-027 Prophylaxis of Post ERCP Pancreatitis in the UK. have the Esge Created Consensus?. Gut. 62(Suppl 1). A53.1–A53. 1 indexed citations

Gibson, Michael K., Nicholas J. Clemons, Wayne A. Phillips, et al.. (2013). Barrett's esophagus: cancer and molecular biology. Annals of the New York Academy of Sciences. 1300(1). 296–314. 21 indexed citations

Farrant, J. Mark, et al.. (2011). Hepatocyte nuclear factor 4 (HNF4 ) provokes intestinal genes in squamous oesophageal cells. Gut. 60(Suppl 1). A171–A172. 1 indexed citations

Burke, Zoë D., Daniel Eberhard, Chia‐Ning Shen, et al.. (2010). Dexamethasone Treatment Induces the Reprogramming of Pancreatic Acinar Cells to Hepatocytes and Ductal Cells. PLoS ONE. 5(10). e13650–e13650. 26 indexed citations

Farrant, J. Mark, et al.. (2010). The role of Cdx2 in Barrett's metaplasia. Biochemical Society Transactions. 38(2). 364–369. 13 indexed citations

Farrant, J. Mark, Philip O’Connor, & Andrew J. Grainger. (2006). Advanced imaging in rheumatoid arthritis. Skeletal Radiology. 36(4). 269–279. 46 indexed citations

Farrant, J. Mark. (1999). Definition of primary sclerosing cholangitis. Journal of Hepato-Biliary-Pancreatic Surgery. 6(4). 329–332. 1 indexed citations

Farrant, J. Mark, Zoë Traill, Christopher P. Conlon, et al.. (1996). Pigbel-like syndrome in a vegetarian in Oxford.. Gut. 39(2). 336–337. 14 indexed citations

10.

Travis, Simon, J. Mark Farrant, Christopher J. Ricketts, et al.. (1996). Predicting outcome in severe ulcerative colitis.. Gut. 38(6). 905–910. 539 indexed citations breakdown →

11.

Farrant, J. Mark, et al.. (1996). Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. The Lancet. 347(9010). 1212–1217. 268 indexed citations

12.

Ramage, John, et al.. (1995). Serum tumor markers for the diagnosis of cholangiocarcinoma in primary sclerosing cholangitis. Gastroenterology. 108(3). 865–869. 197 indexed citations

13.

Farrant, J. Mark, Karen M. Hayllar, Mark Wilkinson, et al.. (1991). Natural history and prognostic variables in primary sclerosing cholangitis. Gastroenterology. 100(6). 1710–1717. 357 indexed citations

14.

Johnson, P J, et al.. (1991). Etiologic and clinical characteristics of peripheral and hilar cholangiocarcinoma. Cancer. 68(9). 2051–2055. 89 indexed citations

15.

Doherty, Derek G., Peter T. Donaldson, J. Mark Farrant, et al.. (1991). Strong associations between HLA-DQA, DQB and DRB3 alleles and autoimmune chronic active hepatitis demonstrated by PCR oligonucliotide analysis. Journal of Hepatology. 13. S25–S25. 1 indexed citations

16.

Farrant, J. Mark, M.R. JUDGE, & R. P. H. Thompson. (1989). Thrombotic cutaneous nodules and hepatic vein thrombosis in the anticardiolipin syndrome. Clinical and Experimental Dermatology. 14(4). 306–308. 21 indexed citations

17.

Senaldi, Giorgio, S. Magrin, J. Mark Farrant, et al.. (1989). Activation of the complement system in primary sclerosing cholangitis. Gastroenterology. 97(6). 1430–1434. 41 indexed citations

18.

Farrant, J. Mark, Colin G. Taylor, & Stephen Beer. (1988). NEPHROTIC SYNDROME IN CHRONIC LYMPHOCYTIC LEUKAEMIA. British Journal of Haematology. 69(3). 419–419. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact